🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 165 (from laksa002)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa165.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://covid19.trackvaccines.org/vaccines/7/\')), getAhrefsUnparsedNoserviceFromURL(\'https://covid19.trackvaccines.org/vaccines/7/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/covid19.trackvaccines.org\/vaccines\/7\/","crawl_time":1776039266,"first_indexed_time":1604088051,"http_code":200,"src_unparsed":"org,trackvaccines!covid19,\/vaccines\/7\/ s443","src_root_hash":"5896860197286366765","history_drop_reason":null,"meta_title":"Sinovac: CoronaVac – COVID19 Vaccine Tracker","meta_descriptions":[],"attrs_boilerpipe_text":"This site is no longer being updated.\nData are accurate as of 2 Dec 2022.\nVaccine Type:\nInactivated\nVaccine Trial & Approval Tracker\nThis vaccine is approved.\nAbout Trial Phases\nPhase 1:\n8\nTrials\nNCT05583357\nChina\nNCT05228613\nIndonesia\nNCT05226429\nIndonesia\nNCT05109559\nThailand\nNCT05043259\nChina\nNCT04352608\nChina\nNCT04383574\nChina\nNCT04551547\nChina\nPhase 2:\n17\nTrials\nNCT05593042\nChile\nNCT05226429\nIndonesia\nNCT05230940\nTurkey\nNCT04979949\nTurkey\nNCT05087368\nBrazil\nTCTR20210720005\nThailand\nNCT05109559\nThailand\nNCT05043259\nChina\nNCT04992182\nChile\nNCT05049226\nThailand\nPHRR210210-003308\nPhilippines\nNCT05150496\nTurkey\nNCT05254236\nHong Kong\nNCT04884685\nChina\nNCT04352608\nChina\nNCT04383574\nChina\nNCT04551547\nChina\nPhase 3:\n17\nTrials\nNCT05433272\nColombia\nNCT05428592\nPakistan\nNCT05308576\nNCT05204589\nChina\nNCT04942405\nTurkey\nNCT05077176\nTurkey\nNCT04992260\nChile\nPHRR210210-003308\nPhilippines\nNCT05137418\nChina\nNCT05225285\nBrazil\nNCT05156632\nPakistan\nNCT04617483\nChina\nNCT04651790\nChile\nNCT04800133\nHong Kong\nNCT04456595\nBrazil\nNCT04508075, 669\/UN6.KEP\/EC\/2020\nIndonesia\nNCT04582344\nTurkey\nRegistered Trials\nNCT05433272\nPhase 3\nColombia\nTotal Enrollment: 1,400\nOfficial Trial Registration:\nNCT05433272\n(Opens in new tab\/window)\nNCT05428592\nPhase 3\nPakistan\nTotal Enrollment: 1,100\nOfficial Trial Registration:\nNCT05428592\n(Opens in new tab\/window)\nNCT05308576\nPhase 3\nTotal Enrollment: 12,000\nOfficial Trial Registration:\nNCT05308576\n(Opens in new tab\/window)\nNCT05204589\nPhase 3\nChina\nTotal Enrollment: 10,420\nOfficial Trial Registration:\nNCT05204589\n(Opens in new tab\/window)\nNCT04942405\nPhase 3\nTurkey\nTotal Enrollment: 40,800\nOfficial Trial Registration:\nNCT04942405\n(Opens in new tab\/window)\nNCT05077176\nPhase 3\nTurkey\nTotal Enrollment: 7,400\nOfficial Trial Registration:\nNCT05077176\n(Opens in new tab\/window)\nNCT04992260\nPhase 3\nChile\nTotal Enrollment: 14,000\nOfficial Trial Registration:\nNCT04992260\n(Opens in new tab\/window)\nNCT05137418\nPhase 3\nChina\nTotal Enrollment: 1,000\nOfficial Trial Registration:\nNCT05137418\n(Opens in new tab\/window)\nNCT05225285\nPhase 3\nBrazil\nTotal Enrollment: 1,120\nOfficial Trial Registration:\nNCT05225285\n(Opens in new tab\/window)\nNCT05156632\nPhase 3\nPakistan\nTotal Enrollment: 13,800\nOfficial Trial Registration:\nNCT05156632\n(Opens in new tab\/window)\nNCT04617483\nPhase 3\nChina\nTotal Enrollment: 1,040\nOfficial Trial Registration:\nNCT04617483\n(Opens in new tab\/window)\nNCT04651790\nPhase 3\nChile\nTotal Enrollment: 2,300\nOfficial Trial Registration:\nNCT04651790\n(Opens in new tab\/window)\nNCT04800133\nPhase 3\nHong Kong\nTotal Enrollment: 900\nOfficial Trial Registration:\nNCT04800133\n(Opens in new tab\/window)\nNCT04456595\nPhase 3\nBrazil\nTotal Enrollment: 12,688\nOfficial Trial Registration:\nNCT04456595\n(Opens in new tab\/window)\nNCT04508075, 669\/UN6.KEP\/EC\/2020\nPhase 3\nIndonesia\nTotal Enrollment: 1,620\nOfficial Trial Registration:\nNCT04508075\n(Opens in new tab\/window)\n669\/UN6.KEP\/EC\/2020\n(Opens in new tab\/window)\nNCT04582344\nPhase 3\nTurkey\nTotal Enrollment: 13,000\nOfficial Trial Registration:\nNCT04582344\n(Opens in new tab\/window)\nPHRR210210-003308\nPhase 2\/3\nPhilippines\nTotal Enrollment: 352\nOfficial Trial Registration:\nPHRR210210-003308\n(Opens in new tab\/window)\nNCT05593042\nPhase 2\nChile\nTotal Enrollment: 826\nOfficial Trial Registration:\nNCT05593042\n(Opens in new tab\/window)\nNCT05230940\nPhase 2\nTurkey\nTotal Enrollment: 644\nOfficial Trial Registration:\nNCT05230940\n(Opens in new tab\/window)\nNCT04979949\nPhase 2\nTurkey\nTotal Enrollment: 222\nOfficial Trial Registration:\nNCT04979949\n(Opens in new tab\/window)\nNCT05087368\nPhase 2\nBrazil\nTotal Enrollment: 520\nOfficial Trial Registration:\nNCT05087368\n(Opens in new tab\/window)\nTCTR20210720005\nPhase 2\nThailand\nTotal Enrollment: 180\nOfficial Trial Registration:\nTCTR20210720005\n(Opens in new tab\/window)\nNCT04992182\nPhase 2\nChile\nTotal Enrollment: 534\nOfficial Trial Registration:\nNCT04992182\n(Opens in new tab\/window)\nNCT05049226\nPhase 2\nThailand\nTotal Enrollment: 1,320\nOfficial Trial Registration:\nNCT05049226\n(Opens in new tab\/window)\nNCT05150496\nPhase 2\nTurkey\nTotal Enrollment: 640\nOfficial Trial Registration:\nNCT05150496\n(Opens in new tab\/window)\nNCT05254236\nPhase 2\nHong Kong\nTotal Enrollment: 150\nOfficial Trial Registration:\nNCT05254236\n(Opens in new tab\/window)\nNCT04884685\nPhase 2\nChina\nTotal Enrollment: 500\nOfficial Trial Registration:\nNCT04884685\n(Opens in new tab\/window)\nNCT05226429\nPhase 1\/2\nIndonesia\nTotal Enrollment: 495\nOfficial Trial Registration:\nNCT05226429\n(Opens in new tab\/window)\nNCT05109559\nPhase 1\/2\nThailand\nTotal Enrollment: 690\nOfficial Trial Registration:\nNCT05109559\n(Opens in new tab\/window)\nNCT05043259\nPhase 1\/2\nChina\nTotal Enrollment: 420\nOfficial Trial Registration:\nNCT05043259\n(Opens in new tab\/window)\nNCT04352608\nPhase 1\/2\nChina\nTotal Enrollment: 744\nOfficial Trial Registration:\nNCT04352608\n(Opens in new tab\/window)\nNCT04383574\nPhase 1\/2\nChina\nTotal Enrollment: 422\nOfficial Trial Registration:\nNCT04383574\n(Opens in new tab\/window)\nNCT04551547\nPhase 1\/2\nChina\nTotal Enrollment: 552\nOfficial Trial Registration:\nNCT04551547\n(Opens in new tab\/window)\nNCT05583357\nPhase 1\nChina\nTotal Enrollment: 40\nOfficial Trial Registration:\nNCT05583357\n(Opens in new tab\/window)\nNCT05228613\nPhase 1\nIndonesia\nTotal Enrollment: 175\nOfficial Trial Registration:\nNCT05228613\n(Opens in new tab\/window)","attrs_markdown":"[Skip to Content](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#content)\n\nThis site is no longer being updated. Data are accurate as of 2 Dec 2022.\n\n[![COVID-19 Vaccine Tracker](https:\/\/covid19.trackvaccines.org\/wp-content\/uploads\/2020\/09\/new-logo-draft.png)](https:\/\/covid19.trackvaccines.org\/)\n\nMenu\n\n- [Home](https:\/\/covid19.trackvaccines.org\/)\n- [Explore Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Approved Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/approved\/)\n  - [Vaccine Candidates](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Global Landscape](https:\/\/covid19.trackvaccines.org\/trials-vaccines-by-country\/)\n- [About Vaccines & Trials](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/)\n  - [How many types of COVID-19 vaccines are there?](https:\/\/covid19.trackvaccines.org\/vaccine-types\/)\n  - [How do COVID-19 vaccines work?](https:\/\/covid19.trackvaccines.org\/how-vaccines-work\/)\n  - [What are the benefits of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/benefits-of-vaccines\/)\n  - [What are the possible side effects of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-side-effects\/)\n  - [Do COVID-19 vaccines work against variants of concern?](https:\/\/covid19.trackvaccines.org\/voc\/)\n  - [Which COVID-19 vaccine should I get?](https:\/\/covid19.trackvaccines.org\/which-vaccine-to-get\/)\n  - [Do I need to get vaccinated if I’ve already had COVID-19?](https:\/\/covid19.trackvaccines.org\/already-had-covid-19\/)\n  - [How do I critically assess vaccine information?](https:\/\/covid19.trackvaccines.org\/heads\/)\n  - [How are vaccines tested?](https:\/\/covid19.trackvaccines.org\/how-are-vaccines-tested\/)\n  - [How is vaccine efficacy assessed?](https:\/\/covid19.trackvaccines.org\/vaccine-efficacy\/)\n  - [How were COVID-19 vaccines developed so quickly?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-development\/)\n  - [How are COVID-19 vaccines approved, including emergency use authorization?](https:\/\/covid19.trackvaccines.org\/vaccine-approval-and-eua\/)\n- [About](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/)\n  - [Data Sources](https:\/\/covid19.trackvaccines.org\/data-sources\/)\n  - [Our Team](https:\/\/covid19.trackvaccines.org\/our-team\/)\n  - [Press Room](https:\/\/covid19.trackvaccines.org\/press-room\/)\n  - [Contact Us](https:\/\/covid19.trackvaccines.org\/contact-us\/)\n\n- [Home](https:\/\/covid19.trackvaccines.org\/)\n- [Explore Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Approved Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/approved\/)\n  - [Vaccine Candidates](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Global Landscape](https:\/\/covid19.trackvaccines.org\/trials-vaccines-by-country\/)\n- [About Vaccines & Trials](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/)\n  - [How many types of COVID-19 vaccines are there?](https:\/\/covid19.trackvaccines.org\/vaccine-types\/)\n  - [How do COVID-19 vaccines work?](https:\/\/covid19.trackvaccines.org\/how-vaccines-work\/)\n  - [What are the benefits of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/benefits-of-vaccines\/)\n  - [What are the possible side effects of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-side-effects\/)\n  - [Do COVID-19 vaccines work against variants of concern?](https:\/\/covid19.trackvaccines.org\/voc\/)\n  - [Which COVID-19 vaccine should I get?](https:\/\/covid19.trackvaccines.org\/which-vaccine-to-get\/)\n  - [Do I need to get vaccinated if I’ve already had COVID-19?](https:\/\/covid19.trackvaccines.org\/already-had-covid-19\/)\n  - [How do I critically assess vaccine information?](https:\/\/covid19.trackvaccines.org\/heads\/)\n  - [How are vaccines tested?](https:\/\/covid19.trackvaccines.org\/how-are-vaccines-tested\/)\n  - [How is vaccine efficacy assessed?](https:\/\/covid19.trackvaccines.org\/vaccine-efficacy\/)\n  - [How were COVID-19 vaccines developed so quickly?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-development\/)\n  - [How are COVID-19 vaccines approved, including emergency use authorization?](https:\/\/covid19.trackvaccines.org\/vaccine-approval-and-eua\/)\n- [About](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/)\n  - [Data Sources](https:\/\/covid19.trackvaccines.org\/data-sources\/)\n  - [Our Team](https:\/\/covid19.trackvaccines.org\/our-team\/)\n  - [Press Room](https:\/\/covid19.trackvaccines.org\/press-room\/)\n  - [Contact Us](https:\/\/covid19.trackvaccines.org\/contact-us\/)\n\n# Sinovac: CoronaVac\n# Sinovac: CoronaVac\nVaccine Type: [Inactivated](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n\n## Vaccine Trial & Approval Tracker\n- Phase 1\n- Phase 2\n- Phase 3\n- Approved\n\nThis vaccine is approved.\n\n[About Trial Phases](https:\/\/covid19.trackvaccines.org\/trials-vaccine-testing\/#trial-phases)\n\n### Phase 1:  8  Trials\n- [**NCT05583357**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05583357)  \n   China\n- [**NCT05228613**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05228613)  \n   Indonesia\n- [**NCT05226429**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05226429)  \n   Indonesia\n- [**NCT05109559**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05109559)  \n   Thailand\n- [**NCT05043259**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05043259)  \n   China\n- [**NCT04352608**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04352608)  \n   China\n- [**NCT04383574**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04383574)  \n   China\n- [**NCT04551547**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04551547)  \n   China\n\n### Phase 2:  17  Trials\n- [**NCT05593042**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05593042)  \n   Chile\n- [**NCT05226429**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05226429)  \n   Indonesia\n- [**NCT05230940**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05230940)  \n   Turkey\n- [**NCT04979949**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04979949)  \n   Turkey\n- [**NCT05087368**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05087368)  \n   Brazil\n- [**TCTR20210720005**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-tctr20210720005)  \n   Thailand\n- [**NCT05109559**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05109559)  \n   Thailand\n- [**NCT05043259**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05043259)  \n   China\n- [**NCT04992182**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04992182)  \n   Chile\n- [**NCT05049226**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05049226)  \n   Thailand\n- [**PHRR210210-003308**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-phrr210210-003308)  \n   Philippines\n- [**NCT05150496**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05150496)  \n   Turkey\n- [**NCT05254236**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05254236)  \n   Hong Kong\n- [**NCT04884685**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04884685)  \n   China\n- [**NCT04352608**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04352608)  \n   China\n- [**NCT04383574**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04383574)  \n   China\n- [**NCT04551547**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04551547)  \n   China\n\n### Phase 3:  17  Trials\n- [**NCT05433272**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05433272)  \n   Colombia\n- [**NCT05428592**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05428592)  \n   Pakistan\n- [**NCT05308576**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05308576)\n- [**NCT05204589**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05204589)  \n   China\n- [**NCT04942405**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04942405)  \n   Turkey\n- [**NCT05077176**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05077176)  \n   Turkey\n- [**NCT04992260**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04992260)  \n   Chile\n- [**PHRR210210-003308**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-phrr210210-003308)  \n   Philippines\n- [**NCT05137418**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05137418)  \n   China\n- [**NCT05225285**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05225285)  \n   Brazil\n- [**NCT05156632**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05156632)  \n   Pakistan\n- [**NCT04617483**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04617483)  \n   China\n- [**NCT04651790**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04651790)  \n   Chile\n- [**NCT04800133**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04800133)  \n   Hong Kong\n- [**NCT04456595**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04456595)  \n   Brazil\n- [**NCT04508075, 669\/UN6.KEP\/EC\/2020**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04508075-669un6-kepec2020)  \n   Indonesia\n- [**NCT04582344**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04582344)  \n   Turkey\n\n### Approvals\n![](https:\/\/covid19.trackvaccines.org\/wp-content\/mu-plugins\/mcgill-vaccinetracker-content\/global\/img\/africa-cdc-logo.png) [Africa Regulatory Taskforce Endorsed](https:\/\/covid19.trackvaccines.org\/agency\/art\/)\n\n![](https:\/\/covid19.trackvaccines.org\/wp-content\/mu-plugins\/mcgill-vaccinetracker-content\/global\/img\/carpha-logo.png) [Caribbean Regulatory System Emergency Use Recommendation](https:\/\/covid19.trackvaccines.org\/agency\/crs\/)\n\n![](https:\/\/covid19.trackvaccines.org\/wp-content\/mu-plugins\/mcgill-vaccinetracker-content\/global\/img\/who-logo.png) [WHO Emergency Use Listing](https:\/\/covid19.trackvaccines.org\/agency\/who\/)\n\n#### 56 Countries\n- [Albania](https:\/\/covid19.trackvaccines.org\/country\/albania\/)\n- [Algeria](https:\/\/covid19.trackvaccines.org\/country\/algeria\/)\n- [Argentina](https:\/\/covid19.trackvaccines.org\/country\/argentina\/)\n- [Armenia](https:\/\/covid19.trackvaccines.org\/country\/armenia\/)\n- [Azerbaijan](https:\/\/covid19.trackvaccines.org\/country\/azerbaijan\/)\n- [Bangladesh](https:\/\/covid19.trackvaccines.org\/country\/bangladesh\/)\n- [Benin](https:\/\/covid19.trackvaccines.org\/country\/benin\/)\n- [Bolivia (Plurinational State of)](https:\/\/covid19.trackvaccines.org\/country\/bolivia-plurinational-state-of\/)\n- [Bosnia and Herzegovina](https:\/\/covid19.trackvaccines.org\/country\/bosnia-and-herzegovina\/)\n- [Botswana](https:\/\/covid19.trackvaccines.org\/country\/botswana\/)\n- [Brazil](https:\/\/covid19.trackvaccines.org\/country\/brazil\/)\n- [Burkina Faso](https:\/\/covid19.trackvaccines.org\/country\/burkina-faso\/)\n- [Cambodia](https:\/\/covid19.trackvaccines.org\/country\/cambodia\/)\n- [Chile](https:\/\/covid19.trackvaccines.org\/country\/chile\/)\n- [China](https:\/\/covid19.trackvaccines.org\/country\/china\/)\n- [Colombia](https:\/\/covid19.trackvaccines.org\/country\/colombia\/)\n- [Djibouti](https:\/\/covid19.trackvaccines.org\/country\/djibouti\/)\n- [Dominican Republic](https:\/\/covid19.trackvaccines.org\/country\/dominican-republic\/)\n- [Ecuador](https:\/\/covid19.trackvaccines.org\/country\/ecuador\/)\n- [Egypt](https:\/\/covid19.trackvaccines.org\/country\/egypt\/)\n- [El Salvador](https:\/\/covid19.trackvaccines.org\/country\/el-salvador\/)\n- [Georgia](https:\/\/covid19.trackvaccines.org\/country\/georgia\/)\n- [Guinea](https:\/\/covid19.trackvaccines.org\/country\/guinea\/)\n- [Hong Kong](https:\/\/covid19.trackvaccines.org\/country\/hong-kong\/)\n- [Indonesia](https:\/\/covid19.trackvaccines.org\/country\/indonesia\/)\n- [Kazakhstan](https:\/\/covid19.trackvaccines.org\/country\/kazakhstan\/)\n- [Lao People's Democratic Republic](https:\/\/covid19.trackvaccines.org\/country\/lao-peoples-democratic-republic\/)\n- [Libya](https:\/\/covid19.trackvaccines.org\/country\/libya\/)\n- [Malawi](https:\/\/covid19.trackvaccines.org\/country\/malawi\/)\n- [Malaysia](https:\/\/covid19.trackvaccines.org\/country\/malaysia\/)\n- [Mali](https:\/\/covid19.trackvaccines.org\/country\/mali\/)\n- [Mexico](https:\/\/covid19.trackvaccines.org\/country\/mexico\/)\n- [Montenegro](https:\/\/covid19.trackvaccines.org\/country\/montenegro\/)\n- [Nepal](https:\/\/covid19.trackvaccines.org\/country\/nepal\/)\n- [Oman](https:\/\/covid19.trackvaccines.org\/country\/oman\/)\n- [Pakistan](https:\/\/covid19.trackvaccines.org\/country\/pakistan\/)\n- [Panama](https:\/\/covid19.trackvaccines.org\/country\/panama\/)\n- [Paraguay](https:\/\/covid19.trackvaccines.org\/country\/paraguay\/)\n- [Philippines](https:\/\/covid19.trackvaccines.org\/country\/philippines\/)\n- [Republic of Moldova](https:\/\/covid19.trackvaccines.org\/country\/republic-of-moldova\/)\n- [Singapore](https:\/\/covid19.trackvaccines.org\/country\/singapore\/)\n- [South Africa](https:\/\/covid19.trackvaccines.org\/country\/south-africa\/)\n- [Sri Lanka](https:\/\/covid19.trackvaccines.org\/country\/sri-lanka\/)\n- [Tajikistan](https:\/\/covid19.trackvaccines.org\/country\/tajikistan\/)\n- [Thailand](https:\/\/covid19.trackvaccines.org\/country\/thailand\/)\n- [Timor-Leste](https:\/\/covid19.trackvaccines.org\/country\/timor-leste\/)\n- [Togo](https:\/\/covid19.trackvaccines.org\/country\/togo\/)\n- [Trinidad and Tobago](https:\/\/covid19.trackvaccines.org\/country\/trinidad-and-tobago\/)\n- [Tunisia](https:\/\/covid19.trackvaccines.org\/country\/tunisia\/)\n- [Turkey](https:\/\/covid19.trackvaccines.org\/country\/turkey\/)\n- [Uganda](https:\/\/covid19.trackvaccines.org\/country\/uganda\/)\n- [Ukraine](https:\/\/covid19.trackvaccines.org\/country\/ukraine\/)\n- [United Republic of Tanzania](https:\/\/covid19.trackvaccines.org\/country\/united-republic-of-tanzania\/)\n- [Uruguay](https:\/\/covid19.trackvaccines.org\/country\/uruguay\/)\n- [Venezuela (Bolivarian Republic of)](https:\/\/covid19.trackvaccines.org\/country\/venezuela-bolivarian-republic-of\/)\n- [Zimbabwe](https:\/\/covid19.trackvaccines.org\/country\/zimbabwe\/)\n## Registered Trials\n- ### NCT05433272\n  Phase 3\n  Colombia\n  Total Enrollment: 1,400\n  #### Official Trial Registration:\n  - [NCT05433272(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05433272)\n- ### NCT05428592\n  Phase 3\n  Pakistan\n  Total Enrollment: 1,100\n  #### Official Trial Registration:\n  - [NCT05428592(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05428592)\n- ### NCT05308576\n  Phase 3\n  Total Enrollment: 12,000\n  #### Official Trial Registration:\n  - [NCT05308576(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05308576)\n- ### NCT05204589\n  Phase 3\n  China\n  Total Enrollment: 10,420\n  #### Official Trial Registration:\n  - [NCT05204589(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05204589)\n- ### NCT04942405\n  Phase 3\n  Turkey\n  Total Enrollment: 40,800\n  #### Official Trial Registration:\n  - [NCT04942405(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04942405)\n- ### NCT05077176\n  Phase 3\n  Turkey\n  Total Enrollment: 7,400\n  #### Official Trial Registration:\n  - [NCT05077176(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05077176)\n- ### NCT04992260\n  Phase 3\n  Chile\n  Total Enrollment: 14,000\n  #### Official Trial Registration:\n  - [NCT04992260(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04992260)\n- ### NCT05137418\n  Phase 3\n  China\n  Total Enrollment: 1,000\n  #### Official Trial Registration:\n  - [NCT05137418(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05137418)\n- ### NCT05225285\n  Phase 3\n  Brazil\n  Total Enrollment: 1,120\n  #### Official Trial Registration:\n  - [NCT05225285(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05225285)\n- ### NCT05156632\n  Phase 3\n  Pakistan\n  Total Enrollment: 13,800\n  #### Official Trial Registration:\n  - [NCT05156632(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05156632)\n- ### NCT04617483\n  Phase 3\n  China\n  Total Enrollment: 1,040\n  #### Official Trial Registration:\n  - [NCT04617483(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04617483)\n- ### NCT04651790\n  Phase 3\n  Chile\n  Total Enrollment: 2,300\n  #### Official Trial Registration:\n  - [NCT04651790(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04651790?term=vaccination&cond=covid&draw=2&rank=10)\n- ### NCT04800133\n  Phase 3\n  Hong Kong\n  Total Enrollment: 900\n  #### Official Trial Registration:\n  - [NCT04800133(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04800133?term=NCT04800133&draw=2&rank=1)\n- ### NCT04456595\n  Phase 3\n  Brazil\n  Total Enrollment: 12,688\n  #### Official Trial Registration:\n  - [NCT04456595(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04456595)\n- ### NCT04508075, 669\/UN6.KEP\/EC\/2020\n  Phase 3\n  Indonesia\n  Total Enrollment: 1,620\n  #### Official Trial Registration:\n  - [NCT04508075(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04508075)\n  - [669\/UN6.KEP\/EC\/2020(Opens in new tab\/window)](https:\/\/www.ina-registry.org\/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX)\n- ### NCT04582344\n  Phase 3\n  Turkey\n  Total Enrollment: 13,000\n  #### Official Trial Registration:\n  - [NCT04582344(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04582344)\n- ### PHRR210210-003308\n  Phase 2\/3\n  Philippines\n  Total Enrollment: 352\n  #### Official Trial Registration:\n  - [PHRR210210-003308(Opens in new tab\/window)](https:\/\/registry.healthresearch.ph\/index.php\/registry?view=research&layout=details&cid=3308)\n- ### NCT05593042\n  Phase 2\n  Chile\n  Total Enrollment: 826\n  #### Official Trial Registration:\n  - [NCT05593042(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05593042)\n- ### NCT05230940\n  Phase 2\n  Turkey\n  Total Enrollment: 644\n  #### Official Trial Registration:\n  - [NCT05230940(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05230940)\n- ### NCT04979949\n  Phase 2\n  Turkey\n  Total Enrollment: 222\n  #### Official Trial Registration:\n  - [NCT04979949(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04979949)\n- ### NCT05087368\n  Phase 2\n  Brazil\n  Total Enrollment: 520\n  #### Official Trial Registration:\n  - [NCT05087368(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05087368)\n- ### TCTR20210720005\n  Phase 2\n  Thailand\n  Total Enrollment: 180\n  #### Official Trial Registration:\n  - [TCTR20210720005(Opens in new tab\/window)](https:\/\/www.thaiclinicaltrials.org\/show\/TCTR20210720005)\n- ### NCT04992182\n  Phase 2\n  Chile\n  Total Enrollment: 534\n  #### Official Trial Registration:\n  - [NCT04992182(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04992182)\n- ### NCT05049226\n  Phase 2\n  Thailand\n  Total Enrollment: 1,320\n  #### Official Trial Registration:\n  - [NCT05049226(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05049226)\n- ### NCT05150496\n  Phase 2\n  Turkey\n  Total Enrollment: 640\n  #### Official Trial Registration:\n  - [NCT05150496(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05150496)\n- ### NCT05254236\n  Phase 2\n  Hong Kong\n  Total Enrollment: 150\n  #### Official Trial Registration:\n  - [NCT05254236(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05254236)\n- ### NCT04884685\n  Phase 2\n  China\n  Total Enrollment: 500\n  #### Official Trial Registration:\n  - [NCT04884685(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04884685?term=NCT04884685&draw=2&rank=1)\n- ### NCT05226429\n  Phase 1\/2\n  Indonesia\n  Total Enrollment: 495\n  #### Official Trial Registration:\n  - [NCT05226429(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05226429)\n- ### NCT05109559\n  Phase 1\/2\n  Thailand\n  Total Enrollment: 690\n  #### Official Trial Registration:\n  - [NCT05109559(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05109559)\n- ### NCT05043259\n  Phase 1\/2\n  China\n  Total Enrollment: 420\n  #### Official Trial Registration:\n  - [NCT05043259(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05043259)\n- ### NCT04352608\n  Phase 1\/2\n  China\n  Total Enrollment: 744\n  #### Official Trial Registration:\n  - [NCT04352608(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/show\/NCT04352608)\n- ### NCT04383574\n  Phase 1\/2\n  China\n  Total Enrollment: 422\n  #### Official Trial Registration:\n  - [NCT04383574(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/show\/NCT04383574)\n- ### NCT04551547\n  Phase 1\/2\n  China\n  Total Enrollment: 552\n  #### Official Trial Registration:\n  - [NCT04551547(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04551547)\n- ### NCT05583357\n  Phase 1\n  China\n  Total Enrollment: 40\n  #### Official Trial Registration:\n  - [NCT05583357(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05583357)\n- ### NCT05228613\n  Phase 1\n  Indonesia\n  Total Enrollment: 175\n  #### Official Trial Registration:\n  - [NCT05228613(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05228613)\n\n© 2026 [VIPER Group COVID19 Vaccine Tracker Team](https:\/\/covid19.trackvaccines.org\/ \"COVID19 Vaccine Tracker\")\n\nFunding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)\n\nThis site is provided for informational purposes only based on publically available data.\n\n[Site Credits](https:\/\/covid19.trackvaccines.org\/site-credits\/) \\| [Website Feedback Form](https:\/\/covid19.trackvaccines.org\/website-feedback\/)","attrs_readable_markdown":"This site is no longer being updated. Data are accurate as of 2 Dec 2022.\n\nVaccine Type: [Inactivated](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n\n## Vaccine Trial & Approval Tracker\nThis vaccine is approved.\n\n[About Trial Phases](https:\/\/covid19.trackvaccines.org\/trials-vaccine-testing\/#trial-phases)\n\n### Phase 1:  8  Trials\n- [**NCT05583357**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05583357)  \n   China\n- [**NCT05228613**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05228613)  \n   Indonesia\n- [**NCT05226429**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05226429)  \n   Indonesia\n- [**NCT05109559**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05109559)  \n   Thailand\n- [**NCT05043259**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05043259)  \n   China\n- [**NCT04352608**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04352608)  \n   China\n- [**NCT04383574**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04383574)  \n   China\n- [**NCT04551547**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04551547)  \n   China\n\n### Phase 2:  17  Trials\n- [**NCT05593042**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05593042)  \n   Chile\n- [**NCT05226429**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05226429)  \n   Indonesia\n- [**NCT05230940**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05230940)  \n   Turkey\n- [**NCT04979949**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04979949)  \n   Turkey\n- [**NCT05087368**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05087368)  \n   Brazil\n- [**TCTR20210720005**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-tctr20210720005)  \n   Thailand\n- [**NCT05109559**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05109559)  \n   Thailand\n- [**NCT05043259**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05043259)  \n   China\n- [**NCT04992182**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04992182)  \n   Chile\n- [**NCT05049226**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05049226)  \n   Thailand\n- [**PHRR210210-003308**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-phrr210210-003308)  \n   Philippines\n- [**NCT05150496**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05150496)  \n   Turkey\n- [**NCT05254236**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05254236)  \n   Hong Kong\n- [**NCT04884685**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04884685)  \n   China\n- [**NCT04352608**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04352608)  \n   China\n- [**NCT04383574**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04383574)  \n   China\n- [**NCT04551547**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04551547)  \n   China\n\n### Phase 3:  17  Trials\n- [**NCT05433272**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05433272)  \n   Colombia\n- [**NCT05428592**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05428592)  \n   Pakistan\n- [**NCT05308576**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05308576)\n- [**NCT05204589**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05204589)  \n   China\n- [**NCT04942405**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04942405)  \n   Turkey\n- [**NCT05077176**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05077176)  \n   Turkey\n- [**NCT04992260**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04992260)  \n   Chile\n- [**PHRR210210-003308**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-phrr210210-003308)  \n   Philippines\n- [**NCT05137418**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05137418)  \n   China\n- [**NCT05225285**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05225285)  \n   Brazil\n- [**NCT05156632**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct05156632)  \n   Pakistan\n- [**NCT04617483**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04617483)  \n   China\n- [**NCT04651790**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04651790)  \n   Chile\n- [**NCT04800133**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04800133)  \n   Hong Kong\n- [**NCT04456595**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04456595)  \n   Brazil\n- [**NCT04508075, 669\/UN6.KEP\/EC\/2020**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04508075-669un6-kepec2020)  \n   Indonesia\n- [**NCT04582344**](https:\/\/covid19.trackvaccines.org\/vaccines\/7\/#trial-nct04582344)  \n   Turkey\n## Registered Trials\n- ### NCT05433272\n  Phase 3\n  Colombia\n  Total Enrollment: 1,400\n  #### Official Trial Registration:\n  - [NCT05433272(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05433272)\n- ### NCT05428592\n  Phase 3\n  Pakistan\n  Total Enrollment: 1,100\n  #### Official Trial Registration:\n  - [NCT05428592(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05428592)\n- ### NCT05308576\n  Phase 3\n  Total Enrollment: 12,000\n  #### Official Trial Registration:\n  - [NCT05308576(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05308576)\n- ### NCT05204589\n  Phase 3\n  China\n  Total Enrollment: 10,420\n  #### Official Trial Registration:\n  - [NCT05204589(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05204589)\n- ### NCT04942405\n  Phase 3\n  Turkey\n  Total Enrollment: 40,800\n  #### Official Trial Registration:\n  - [NCT04942405(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04942405)\n- ### NCT05077176\n  Phase 3\n  Turkey\n  Total Enrollment: 7,400\n  #### Official Trial Registration:\n  - [NCT05077176(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05077176)\n- ### NCT04992260\n  Phase 3\n  Chile\n  Total Enrollment: 14,000\n  #### Official Trial Registration:\n  - [NCT04992260(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04992260)\n- ### NCT05137418\n  Phase 3\n  China\n  Total Enrollment: 1,000\n  #### Official Trial Registration:\n  - [NCT05137418(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05137418)\n- ### NCT05225285\n  Phase 3\n  Brazil\n  Total Enrollment: 1,120\n  #### Official Trial Registration:\n  - [NCT05225285(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05225285)\n- ### NCT05156632\n  Phase 3\n  Pakistan\n  Total Enrollment: 13,800\n  #### Official Trial Registration:\n  - [NCT05156632(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05156632)\n- ### NCT04617483\n  Phase 3\n  China\n  Total Enrollment: 1,040\n  #### Official Trial Registration:\n  - [NCT04617483(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04617483)\n- ### NCT04651790\n  Phase 3\n  Chile\n  Total Enrollment: 2,300\n  #### Official Trial Registration:\n  - [NCT04651790(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04651790?term=vaccination&cond=covid&draw=2&rank=10)\n- ### NCT04800133\n  Phase 3\n  Hong Kong\n  Total Enrollment: 900\n  #### Official Trial Registration:\n  - [NCT04800133(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04800133?term=NCT04800133&draw=2&rank=1)\n- ### NCT04456595\n  Phase 3\n  Brazil\n  Total Enrollment: 12,688\n  #### Official Trial Registration:\n  - [NCT04456595(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04456595)\n- ### NCT04508075, 669\/UN6.KEP\/EC\/2020\n  Phase 3\n  Indonesia\n  Total Enrollment: 1,620\n  #### Official Trial Registration:\n  - [NCT04508075(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04508075)\n  - [669\/UN6.KEP\/EC\/2020(Opens in new tab\/window)](https:\/\/www.ina-registry.org\/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX)\n- ### NCT04582344\n  Phase 3\n  Turkey\n  Total Enrollment: 13,000\n  #### Official Trial Registration:\n  - [NCT04582344(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04582344)\n- ### PHRR210210-003308\n  Phase 2\/3\n  Philippines\n  Total Enrollment: 352\n  #### Official Trial Registration:\n  - [PHRR210210-003308(Opens in new tab\/window)](https:\/\/registry.healthresearch.ph\/index.php\/registry?view=research&layout=details&cid=3308)\n- ### NCT05593042\n  Phase 2\n  Chile\n  Total Enrollment: 826\n  #### Official Trial Registration:\n  - [NCT05593042(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05593042)\n- ### NCT05230940\n  Phase 2\n  Turkey\n  Total Enrollment: 644\n  #### Official Trial Registration:\n  - [NCT05230940(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05230940)\n- ### NCT04979949\n  Phase 2\n  Turkey\n  Total Enrollment: 222\n  #### Official Trial Registration:\n  - [NCT04979949(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04979949)\n- ### NCT05087368\n  Phase 2\n  Brazil\n  Total Enrollment: 520\n  #### Official Trial Registration:\n  - [NCT05087368(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05087368)\n- ### TCTR20210720005\n  Phase 2\n  Thailand\n  Total Enrollment: 180\n  #### Official Trial Registration:\n  - [TCTR20210720005(Opens in new tab\/window)](https:\/\/www.thaiclinicaltrials.org\/show\/TCTR20210720005)\n- ### NCT04992182\n  Phase 2\n  Chile\n  Total Enrollment: 534\n  #### Official Trial Registration:\n  - [NCT04992182(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04992182)\n- ### NCT05049226\n  Phase 2\n  Thailand\n  Total Enrollment: 1,320\n  #### Official Trial Registration:\n  - [NCT05049226(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05049226)\n- ### NCT05150496\n  Phase 2\n  Turkey\n  Total Enrollment: 640\n  #### Official Trial Registration:\n  - [NCT05150496(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05150496)\n- ### NCT05254236\n  Phase 2\n  Hong Kong\n  Total Enrollment: 150\n  #### Official Trial Registration:\n  - [NCT05254236(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05254236)\n- ### NCT04884685\n  Phase 2\n  China\n  Total Enrollment: 500\n  #### Official Trial Registration:\n  - [NCT04884685(Opens in new tab\/window)](https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04884685?term=NCT04884685&draw=2&rank=1)\n- ### NCT05226429\n  Phase 1\/2\n  Indonesia\n  Total Enrollment: 495\n  #### Official Trial Registration:\n  - [NCT05226429(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05226429)\n- ### NCT05109559\n  Phase 1\/2\n  Thailand\n  Total Enrollment: 690\n  #### Official Trial Registration:\n  - [NCT05109559(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05109559)\n- ### NCT05043259\n  Phase 1\/2\n  China\n  Total Enrollment: 420\n  #### Official Trial Registration:\n  - [NCT05043259(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05043259)\n- ### NCT04352608\n  Phase 1\/2\n  China\n  Total Enrollment: 744\n  #### Official Trial Registration:\n  - [NCT04352608(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/show\/NCT04352608)\n- ### NCT04383574\n  Phase 1\/2\n  China\n  Total Enrollment: 422\n  #### Official Trial Registration:\n  - [NCT04383574(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/show\/NCT04383574)\n- ### NCT04551547\n  Phase 1\/2\n  China\n  Total Enrollment: 552\n  #### Official Trial Registration:\n  - [NCT04551547(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04551547)\n- ### NCT05583357\n  Phase 1\n  China\n  Total Enrollment: 40\n  #### Official Trial Registration:\n  - [NCT05583357(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05583357)\n- ### NCT05228613\n  Phase 1\n  Indonesia\n  Total Enrollment: 175\n  #### Official Trial Registration:\n  - [NCT05228613(Opens in new tab\/window)](https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05228613)","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

18 minutes ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://covid19.trackvaccines.org/vaccines/7/
Last Crawled	2026-04-13 00:14:26 (18 minutes ago)
First Indexed	2020-10-30 20:00:51 (5 years ago)
HTTP Status Code	200
Meta Title	Sinovac: CoronaVac – COVID19 Vaccine Tracker
Meta Description	null
Meta Canonical	null
Boilerpipe Text	This site is no longer being updated. Data are accurate as of 2 Dec 2022. Vaccine Type: Inactivated Vaccine Trial & Approval Tracker This vaccine is approved. About Trial Phases Phase 1: 8 Trials NCT05583357 China NCT05228613 Indonesia NCT05226429 Indonesia NCT05109559 Thailand NCT05043259 China NCT04352608 China NCT04383574 China NCT04551547 China Phase 2: 17 Trials NCT05593042 Chile NCT05226429 Indonesia NCT05230940 Turkey NCT04979949 Turkey NCT05087368 Brazil TCTR20210720005 Thailand NCT05109559 Thailand NCT05043259 China NCT04992182 Chile NCT05049226 Thailand PHRR210210-003308 Philippines NCT05150496 Turkey NCT05254236 Hong Kong NCT04884685 China NCT04352608 China NCT04383574 China NCT04551547 China Phase 3: 17 Trials NCT05433272 Colombia NCT05428592 Pakistan NCT05308576 NCT05204589 China NCT04942405 Turkey NCT05077176 Turkey NCT04992260 Chile PHRR210210-003308 Philippines NCT05137418 China NCT05225285 Brazil NCT05156632 Pakistan NCT04617483 China NCT04651790 Chile NCT04800133 Hong Kong NCT04456595 Brazil NCT04508075, 669/UN6.KEP/EC/2020 Indonesia NCT04582344 Turkey Registered Trials NCT05433272 Phase 3 Colombia Total Enrollment: 1,400 Official Trial Registration: NCT05433272 (Opens in new tab/window) NCT05428592 Phase 3 Pakistan Total Enrollment: 1,100 Official Trial Registration: NCT05428592 (Opens in new tab/window) NCT05308576 Phase 3 Total Enrollment: 12,000 Official Trial Registration: NCT05308576 (Opens in new tab/window) NCT05204589 Phase 3 China Total Enrollment: 10,420 Official Trial Registration: NCT05204589 (Opens in new tab/window) NCT04942405 Phase 3 Turkey Total Enrollment: 40,800 Official Trial Registration: NCT04942405 (Opens in new tab/window) NCT05077176 Phase 3 Turkey Total Enrollment: 7,400 Official Trial Registration: NCT05077176 (Opens in new tab/window) NCT04992260 Phase 3 Chile Total Enrollment: 14,000 Official Trial Registration: NCT04992260 (Opens in new tab/window) NCT05137418 Phase 3 China Total Enrollment: 1,000 Official Trial Registration: NCT05137418 (Opens in new tab/window) NCT05225285 Phase 3 Brazil Total Enrollment: 1,120 Official Trial Registration: NCT05225285 (Opens in new tab/window) NCT05156632 Phase 3 Pakistan Total Enrollment: 13,800 Official Trial Registration: NCT05156632 (Opens in new tab/window) NCT04617483 Phase 3 China Total Enrollment: 1,040 Official Trial Registration: NCT04617483 (Opens in new tab/window) NCT04651790 Phase 3 Chile Total Enrollment: 2,300 Official Trial Registration: NCT04651790 (Opens in new tab/window) NCT04800133 Phase 3 Hong Kong Total Enrollment: 900 Official Trial Registration: NCT04800133 (Opens in new tab/window) NCT04456595 Phase 3 Brazil Total Enrollment: 12,688 Official Trial Registration: NCT04456595 (Opens in new tab/window) NCT04508075, 669/UN6.KEP/EC/2020 Phase 3 Indonesia Total Enrollment: 1,620 Official Trial Registration: NCT04508075 (Opens in new tab/window) 669/UN6.KEP/EC/2020 (Opens in new tab/window) NCT04582344 Phase 3 Turkey Total Enrollment: 13,000 Official Trial Registration: NCT04582344 (Opens in new tab/window) PHRR210210-003308 Phase 2/3 Philippines Total Enrollment: 352 Official Trial Registration: PHRR210210-003308 (Opens in new tab/window) NCT05593042 Phase 2 Chile Total Enrollment: 826 Official Trial Registration: NCT05593042 (Opens in new tab/window) NCT05230940 Phase 2 Turkey Total Enrollment: 644 Official Trial Registration: NCT05230940 (Opens in new tab/window) NCT04979949 Phase 2 Turkey Total Enrollment: 222 Official Trial Registration: NCT04979949 (Opens in new tab/window) NCT05087368 Phase 2 Brazil Total Enrollment: 520 Official Trial Registration: NCT05087368 (Opens in new tab/window) TCTR20210720005 Phase 2 Thailand Total Enrollment: 180 Official Trial Registration: TCTR20210720005 (Opens in new tab/window) NCT04992182 Phase 2 Chile Total Enrollment: 534 Official Trial Registration: NCT04992182 (Opens in new tab/window) NCT05049226 Phase 2 Thailand Total Enrollment: 1,320 Official Trial Registration: NCT05049226 (Opens in new tab/window) NCT05150496 Phase 2 Turkey Total Enrollment: 640 Official Trial Registration: NCT05150496 (Opens in new tab/window) NCT05254236 Phase 2 Hong Kong Total Enrollment: 150 Official Trial Registration: NCT05254236 (Opens in new tab/window) NCT04884685 Phase 2 China Total Enrollment: 500 Official Trial Registration: NCT04884685 (Opens in new tab/window) NCT05226429 Phase 1/2 Indonesia Total Enrollment: 495 Official Trial Registration: NCT05226429 (Opens in new tab/window) NCT05109559 Phase 1/2 Thailand Total Enrollment: 690 Official Trial Registration: NCT05109559 (Opens in new tab/window) NCT05043259 Phase 1/2 China Total Enrollment: 420 Official Trial Registration: NCT05043259 (Opens in new tab/window) NCT04352608 Phase 1/2 China Total Enrollment: 744 Official Trial Registration: NCT04352608 (Opens in new tab/window) NCT04383574 Phase 1/2 China Total Enrollment: 422 Official Trial Registration: NCT04383574 (Opens in new tab/window) NCT04551547 Phase 1/2 China Total Enrollment: 552 Official Trial Registration: NCT04551547 (Opens in new tab/window) NCT05583357 Phase 1 China Total Enrollment: 40 Official Trial Registration: NCT05583357 (Opens in new tab/window) NCT05228613 Phase 1 Indonesia Total Enrollment: 175 Official Trial Registration: NCT05228613 (Opens in new tab/window)
Markdown	[Skip to Content](https://covid19.trackvaccines.org/vaccines/7/#content) This site is no longer being updated. Data are accurate as of 2 Dec 2022. [![COVID-19 Vaccine Tracker](https://covid19.trackvaccines.org/wp-content/uploads/2020/09/new-logo-draft.png)](https://covid19.trackvaccines.org/) Menu - [Home](https://covid19.trackvaccines.org/) - [Explore Vaccines](https://covid19.trackvaccines.org/vaccines/) - [Approved Vaccines](https://covid19.trackvaccines.org/vaccines/approved/) - [Vaccine Candidates](https://covid19.trackvaccines.org/vaccines/) - [Global Landscape](https://covid19.trackvaccines.org/trials-vaccines-by-country/) - [About Vaccines & Trials](https://covid19.trackvaccines.org/vaccines/7/) - [How many types of COVID-19 vaccines are there?](https://covid19.trackvaccines.org/vaccine-types/) - [How do COVID-19 vaccines work?](https://covid19.trackvaccines.org/how-vaccines-work/) - [What are the benefits of COVID-19 vaccines?](https://covid19.trackvaccines.org/benefits-of-vaccines/) - [What are the possible side effects of COVID-19 vaccines?](https://covid19.trackvaccines.org/covid-19-vaccine-side-effects/) - [Do COVID-19 vaccines work against variants of concern?](https://covid19.trackvaccines.org/voc/) - [Which COVID-19 vaccine should I get?](https://covid19.trackvaccines.org/which-vaccine-to-get/) - [Do I need to get vaccinated if I’ve already had COVID-19?](https://covid19.trackvaccines.org/already-had-covid-19/) - [How do I critically assess vaccine information?](https://covid19.trackvaccines.org/heads/) - [How are vaccines tested?](https://covid19.trackvaccines.org/how-are-vaccines-tested/) - [How is vaccine efficacy assessed?](https://covid19.trackvaccines.org/vaccine-efficacy/) - [How were COVID-19 vaccines developed so quickly?](https://covid19.trackvaccines.org/covid-19-vaccine-development/) - [How are COVID-19 vaccines approved, including emergency use authorization?](https://covid19.trackvaccines.org/vaccine-approval-and-eua/) - [About](https://covid19.trackvaccines.org/vaccines/7/) - [Data Sources](https://covid19.trackvaccines.org/data-sources/) - [Our Team](https://covid19.trackvaccines.org/our-team/) - [Press Room](https://covid19.trackvaccines.org/press-room/) - [Contact Us](https://covid19.trackvaccines.org/contact-us/) - [Home](https://covid19.trackvaccines.org/) - [Explore Vaccines](https://covid19.trackvaccines.org/vaccines/) - [Approved Vaccines](https://covid19.trackvaccines.org/vaccines/approved/) - [Vaccine Candidates](https://covid19.trackvaccines.org/vaccines/) - [Global Landscape](https://covid19.trackvaccines.org/trials-vaccines-by-country/) - [About Vaccines & Trials](https://covid19.trackvaccines.org/vaccines/7/) - [How many types of COVID-19 vaccines are there?](https://covid19.trackvaccines.org/vaccine-types/) - [How do COVID-19 vaccines work?](https://covid19.trackvaccines.org/how-vaccines-work/) - [What are the benefits of COVID-19 vaccines?](https://covid19.trackvaccines.org/benefits-of-vaccines/) - [What are the possible side effects of COVID-19 vaccines?](https://covid19.trackvaccines.org/covid-19-vaccine-side-effects/) - [Do COVID-19 vaccines work against variants of concern?](https://covid19.trackvaccines.org/voc/) - [Which COVID-19 vaccine should I get?](https://covid19.trackvaccines.org/which-vaccine-to-get/) - [Do I need to get vaccinated if I’ve already had COVID-19?](https://covid19.trackvaccines.org/already-had-covid-19/) - [How do I critically assess vaccine information?](https://covid19.trackvaccines.org/heads/) - [How are vaccines tested?](https://covid19.trackvaccines.org/how-are-vaccines-tested/) - [How is vaccine efficacy assessed?](https://covid19.trackvaccines.org/vaccine-efficacy/) - [How were COVID-19 vaccines developed so quickly?](https://covid19.trackvaccines.org/covid-19-vaccine-development/) - [How are COVID-19 vaccines approved, including emergency use authorization?](https://covid19.trackvaccines.org/vaccine-approval-and-eua/) - [About](https://covid19.trackvaccines.org/vaccines/7/) - [Data Sources](https://covid19.trackvaccines.org/data-sources/) - [Our Team](https://covid19.trackvaccines.org/our-team/) - [Press Room](https://covid19.trackvaccines.org/press-room/) - [Contact Us](https://covid19.trackvaccines.org/contact-us/) # Sinovac: CoronaVac # Sinovac: CoronaVac Vaccine Type: [Inactivated](https://covid19.trackvaccines.org/types-of-vaccines/) ## Vaccine Trial & Approval Tracker - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. [About Trial Phases](https://covid19.trackvaccines.org/trials-vaccine-testing/#trial-phases) ### Phase 1: 8 Trials - [NCT05583357](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05583357) China - [NCT05228613](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05228613) Indonesia - [NCT05226429](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05226429) Indonesia - [NCT05109559](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05109559) Thailand - [NCT05043259](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05043259) China - [NCT04352608](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04352608) China - [NCT04383574](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04383574) China - [NCT04551547](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04551547) China ### Phase 2: 17 Trials - [NCT05593042](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05593042) Chile - [NCT05226429](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05226429) Indonesia - [NCT05230940](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05230940) Turkey - [NCT04979949](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04979949) Turkey - [NCT05087368](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05087368) Brazil - [TCTR20210720005](https://covid19.trackvaccines.org/vaccines/7/#trial-tctr20210720005) Thailand - [NCT05109559](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05109559) Thailand - [NCT05043259](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05043259) China - [NCT04992182](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04992182) Chile - [NCT05049226](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05049226) Thailand - [PHRR210210-003308](https://covid19.trackvaccines.org/vaccines/7/#trial-phrr210210-003308) Philippines - [NCT05150496](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05150496) Turkey - [NCT05254236](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05254236) Hong Kong - [NCT04884685](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04884685) China - [NCT04352608](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04352608) China - [NCT04383574](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04383574) China - [NCT04551547](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04551547) China ### Phase 3: 17 Trials - [NCT05433272](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05433272) Colombia - [NCT05428592](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05428592) Pakistan - [NCT05308576](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05308576) - [NCT05204589](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05204589) China - [NCT04942405](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04942405) Turkey - [NCT05077176](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05077176) Turkey - [NCT04992260](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04992260) Chile - [PHRR210210-003308](https://covid19.trackvaccines.org/vaccines/7/#trial-phrr210210-003308) Philippines - [NCT05137418](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05137418) China - [NCT05225285](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05225285) Brazil - [NCT05156632](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05156632) Pakistan - [NCT04617483](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04617483) China - [NCT04651790](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04651790) Chile - [NCT04800133](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04800133) Hong Kong - [NCT04456595](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04456595) Brazil - [NCT04508075, 669/UN6.KEP/EC/2020](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04508075-669un6-kepec2020) Indonesia - [NCT04582344](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04582344) Turkey ### Approvals ![](https://covid19.trackvaccines.org/wp-content/mu-plugins/mcgill-vaccinetracker-content/global/img/africa-cdc-logo.png) [Africa Regulatory Taskforce Endorsed](https://covid19.trackvaccines.org/agency/art/) ![](https://covid19.trackvaccines.org/wp-content/mu-plugins/mcgill-vaccinetracker-content/global/img/carpha-logo.png) [Caribbean Regulatory System Emergency Use Recommendation](https://covid19.trackvaccines.org/agency/crs/) ![](https://covid19.trackvaccines.org/wp-content/mu-plugins/mcgill-vaccinetracker-content/global/img/who-logo.png) [WHO Emergency Use Listing](https://covid19.trackvaccines.org/agency/who/) #### 56 Countries - [Albania](https://covid19.trackvaccines.org/country/albania/) - [Algeria](https://covid19.trackvaccines.org/country/algeria/) - [Argentina](https://covid19.trackvaccines.org/country/argentina/) - [Armenia](https://covid19.trackvaccines.org/country/armenia/) - [Azerbaijan](https://covid19.trackvaccines.org/country/azerbaijan/) - [Bangladesh](https://covid19.trackvaccines.org/country/bangladesh/) - [Benin](https://covid19.trackvaccines.org/country/benin/) - [Bolivia (Plurinational State of)](https://covid19.trackvaccines.org/country/bolivia-plurinational-state-of/) - [Bosnia and Herzegovina](https://covid19.trackvaccines.org/country/bosnia-and-herzegovina/) - [Botswana](https://covid19.trackvaccines.org/country/botswana/) - [Brazil](https://covid19.trackvaccines.org/country/brazil/) - [Burkina Faso](https://covid19.trackvaccines.org/country/burkina-faso/) - [Cambodia](https://covid19.trackvaccines.org/country/cambodia/) - [Chile](https://covid19.trackvaccines.org/country/chile/) - [China](https://covid19.trackvaccines.org/country/china/) - [Colombia](https://covid19.trackvaccines.org/country/colombia/) - [Djibouti](https://covid19.trackvaccines.org/country/djibouti/) - [Dominican Republic](https://covid19.trackvaccines.org/country/dominican-republic/) - [Ecuador](https://covid19.trackvaccines.org/country/ecuador/) - [Egypt](https://covid19.trackvaccines.org/country/egypt/) - [El Salvador](https://covid19.trackvaccines.org/country/el-salvador/) - [Georgia](https://covid19.trackvaccines.org/country/georgia/) - [Guinea](https://covid19.trackvaccines.org/country/guinea/) - [Hong Kong](https://covid19.trackvaccines.org/country/hong-kong/) - [Indonesia](https://covid19.trackvaccines.org/country/indonesia/) - [Kazakhstan](https://covid19.trackvaccines.org/country/kazakhstan/) - [Lao People's Democratic Republic](https://covid19.trackvaccines.org/country/lao-peoples-democratic-republic/) - [Libya](https://covid19.trackvaccines.org/country/libya/) - [Malawi](https://covid19.trackvaccines.org/country/malawi/) - [Malaysia](https://covid19.trackvaccines.org/country/malaysia/) - [Mali](https://covid19.trackvaccines.org/country/mali/) - [Mexico](https://covid19.trackvaccines.org/country/mexico/) - [Montenegro](https://covid19.trackvaccines.org/country/montenegro/) - [Nepal](https://covid19.trackvaccines.org/country/nepal/) - [Oman](https://covid19.trackvaccines.org/country/oman/) - [Pakistan](https://covid19.trackvaccines.org/country/pakistan/) - [Panama](https://covid19.trackvaccines.org/country/panama/) - [Paraguay](https://covid19.trackvaccines.org/country/paraguay/) - [Philippines](https://covid19.trackvaccines.org/country/philippines/) - [Republic of Moldova](https://covid19.trackvaccines.org/country/republic-of-moldova/) - [Singapore](https://covid19.trackvaccines.org/country/singapore/) - [South Africa](https://covid19.trackvaccines.org/country/south-africa/) - [Sri Lanka](https://covid19.trackvaccines.org/country/sri-lanka/) - [Tajikistan](https://covid19.trackvaccines.org/country/tajikistan/) - [Thailand](https://covid19.trackvaccines.org/country/thailand/) - [Timor-Leste](https://covid19.trackvaccines.org/country/timor-leste/) - [Togo](https://covid19.trackvaccines.org/country/togo/) - [Trinidad and Tobago](https://covid19.trackvaccines.org/country/trinidad-and-tobago/) - [Tunisia](https://covid19.trackvaccines.org/country/tunisia/) - [Turkey](https://covid19.trackvaccines.org/country/turkey/) - [Uganda](https://covid19.trackvaccines.org/country/uganda/) - [Ukraine](https://covid19.trackvaccines.org/country/ukraine/) - [United Republic of Tanzania](https://covid19.trackvaccines.org/country/united-republic-of-tanzania/) - [Uruguay](https://covid19.trackvaccines.org/country/uruguay/) - [Venezuela (Bolivarian Republic of)](https://covid19.trackvaccines.org/country/venezuela-bolivarian-republic-of/) - [Zimbabwe](https://covid19.trackvaccines.org/country/zimbabwe/) ## Registered Trials - ### NCT05433272 Phase 3 Colombia Total Enrollment: 1,400 #### Official Trial Registration: - [NCT05433272(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05433272) - ### NCT05428592 Phase 3 Pakistan Total Enrollment: 1,100 #### Official Trial Registration: - [NCT05428592(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05428592) - ### NCT05308576 Phase 3 Total Enrollment: 12,000 #### Official Trial Registration: - [NCT05308576(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05308576) - ### NCT05204589 Phase 3 China Total Enrollment: 10,420 #### Official Trial Registration: - [NCT05204589(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05204589) - ### NCT04942405 Phase 3 Turkey Total Enrollment: 40,800 #### Official Trial Registration: - [NCT04942405(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04942405) - ### NCT05077176 Phase 3 Turkey Total Enrollment: 7,400 #### Official Trial Registration: - [NCT05077176(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05077176) - ### NCT04992260 Phase 3 Chile Total Enrollment: 14,000 #### Official Trial Registration: - [NCT04992260(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04992260) - ### NCT05137418 Phase 3 China Total Enrollment: 1,000 #### Official Trial Registration: - [NCT05137418(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05137418) - ### NCT05225285 Phase 3 Brazil Total Enrollment: 1,120 #### Official Trial Registration: - [NCT05225285(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05225285) - ### NCT05156632 Phase 3 Pakistan Total Enrollment: 13,800 #### Official Trial Registration: - [NCT05156632(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05156632) - ### NCT04617483 Phase 3 China Total Enrollment: 1,040 #### Official Trial Registration: - [NCT04617483(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04617483) - ### NCT04651790 Phase 3 Chile Total Enrollment: 2,300 #### Official Trial Registration: - [NCT04651790(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04651790?term=vaccination&cond=covid&draw=2&rank=10) - ### NCT04800133 Phase 3 Hong Kong Total Enrollment: 900 #### Official Trial Registration: - [NCT04800133(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04800133?term=NCT04800133&draw=2&rank=1) - ### NCT04456595 Phase 3 Brazil Total Enrollment: 12,688 #### Official Trial Registration: - [NCT04456595(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04456595) - ### NCT04508075, 669/UN6.KEP/EC/2020 Phase 3 Indonesia Total Enrollment: 1,620 #### Official Trial Registration: - [NCT04508075(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04508075) - [669/UN6.KEP/EC/2020(Opens in new tab/window)](https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX) - ### NCT04582344 Phase 3 Turkey Total Enrollment: 13,000 #### Official Trial Registration: - [NCT04582344(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04582344) - ### PHRR210210-003308 Phase 2/3 Philippines Total Enrollment: 352 #### Official Trial Registration: - [PHRR210210-003308(Opens in new tab/window)](https://registry.healthresearch.ph/index.php/registry?view=research&layout=details&cid=3308) - ### NCT05593042 Phase 2 Chile Total Enrollment: 826 #### Official Trial Registration: - [NCT05593042(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05593042) - ### NCT05230940 Phase 2 Turkey Total Enrollment: 644 #### Official Trial Registration: - [NCT05230940(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05230940) - ### NCT04979949 Phase 2 Turkey Total Enrollment: 222 #### Official Trial Registration: - [NCT04979949(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04979949) - ### NCT05087368 Phase 2 Brazil Total Enrollment: 520 #### Official Trial Registration: - [NCT05087368(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05087368) - ### TCTR20210720005 Phase 2 Thailand Total Enrollment: 180 #### Official Trial Registration: - [TCTR20210720005(Opens in new tab/window)](https://www.thaiclinicaltrials.org/show/TCTR20210720005) - ### NCT04992182 Phase 2 Chile Total Enrollment: 534 #### Official Trial Registration: - [NCT04992182(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04992182) - ### NCT05049226 Phase 2 Thailand Total Enrollment: 1,320 #### Official Trial Registration: - [NCT05049226(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05049226) - ### NCT05150496 Phase 2 Turkey Total Enrollment: 640 #### Official Trial Registration: - [NCT05150496(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05150496) - ### NCT05254236 Phase 2 Hong Kong Total Enrollment: 150 #### Official Trial Registration: - [NCT05254236(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05254236) - ### NCT04884685 Phase 2 China Total Enrollment: 500 #### Official Trial Registration: - [NCT04884685(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04884685?term=NCT04884685&draw=2&rank=1) - ### NCT05226429 Phase 1/2 Indonesia Total Enrollment: 495 #### Official Trial Registration: - [NCT05226429(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05226429) - ### NCT05109559 Phase 1/2 Thailand Total Enrollment: 690 #### Official Trial Registration: - [NCT05109559(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05109559) - ### NCT05043259 Phase 1/2 China Total Enrollment: 420 #### Official Trial Registration: - [NCT05043259(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05043259) - ### NCT04352608 Phase 1/2 China Total Enrollment: 744 #### Official Trial Registration: - [NCT04352608(Opens in new tab/window)](https://clinicaltrials.gov/show/NCT04352608) - ### NCT04383574 Phase 1/2 China Total Enrollment: 422 #### Official Trial Registration: - [NCT04383574(Opens in new tab/window)](https://clinicaltrials.gov/show/NCT04383574) - ### NCT04551547 Phase 1/2 China Total Enrollment: 552 #### Official Trial Registration: - [NCT04551547(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04551547) - ### NCT05583357 Phase 1 China Total Enrollment: 40 #### Official Trial Registration: - [NCT05583357(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05583357) - ### NCT05228613 Phase 1 Indonesia Total Enrollment: 175 #### Official Trial Registration: - [NCT05228613(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05228613) © 2026 [VIPER Group COVID19 Vaccine Tracker Team](https://covid19.trackvaccines.org/ "COVID19 Vaccine Tracker") Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4) This site is provided for informational purposes only based on publically available data. [Site Credits](https://covid19.trackvaccines.org/site-credits/) \\| [Website Feedback Form](https://covid19.trackvaccines.org/website-feedback/)
Readable Markdown	This site is no longer being updated. Data are accurate as of 2 Dec 2022. Vaccine Type: [Inactivated](https://covid19.trackvaccines.org/types-of-vaccines/) ## Vaccine Trial & Approval Tracker This vaccine is approved. [About Trial Phases](https://covid19.trackvaccines.org/trials-vaccine-testing/#trial-phases) ### Phase 1: 8 Trials - [NCT05583357](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05583357) China - [NCT05228613](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05228613) Indonesia - [NCT05226429](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05226429) Indonesia - [NCT05109559](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05109559) Thailand - [NCT05043259](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05043259) China - [NCT04352608](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04352608) China - [NCT04383574](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04383574) China - [NCT04551547](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04551547) China ### Phase 2: 17 Trials - [NCT05593042](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05593042) Chile - [NCT05226429](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05226429) Indonesia - [NCT05230940](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05230940) Turkey - [NCT04979949](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04979949) Turkey - [NCT05087368](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05087368) Brazil - [TCTR20210720005](https://covid19.trackvaccines.org/vaccines/7/#trial-tctr20210720005) Thailand - [NCT05109559](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05109559) Thailand - [NCT05043259](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05043259) China - [NCT04992182](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04992182) Chile - [NCT05049226](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05049226) Thailand - [PHRR210210-003308](https://covid19.trackvaccines.org/vaccines/7/#trial-phrr210210-003308) Philippines - [NCT05150496](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05150496) Turkey - [NCT05254236](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05254236) Hong Kong - [NCT04884685](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04884685) China - [NCT04352608](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04352608) China - [NCT04383574](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04383574) China - [NCT04551547](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04551547) China ### Phase 3: 17 Trials - [NCT05433272](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05433272) Colombia - [NCT05428592](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05428592) Pakistan - [NCT05308576](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05308576) - [NCT05204589](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05204589) China - [NCT04942405](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04942405) Turkey - [NCT05077176](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05077176) Turkey - [NCT04992260](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04992260) Chile - [PHRR210210-003308](https://covid19.trackvaccines.org/vaccines/7/#trial-phrr210210-003308) Philippines - [NCT05137418](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05137418) China - [NCT05225285](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05225285) Brazil - [NCT05156632](https://covid19.trackvaccines.org/vaccines/7/#trial-nct05156632) Pakistan - [NCT04617483](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04617483) China - [NCT04651790](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04651790) Chile - [NCT04800133](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04800133) Hong Kong - [NCT04456595](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04456595) Brazil - [NCT04508075, 669/UN6.KEP/EC/2020](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04508075-669un6-kepec2020) Indonesia - [NCT04582344](https://covid19.trackvaccines.org/vaccines/7/#trial-nct04582344) Turkey ## Registered Trials - ### NCT05433272 Phase 3 Colombia Total Enrollment: 1,400 #### Official Trial Registration: - [NCT05433272(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05433272) - ### NCT05428592 Phase 3 Pakistan Total Enrollment: 1,100 #### Official Trial Registration: - [NCT05428592(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05428592) - ### NCT05308576 Phase 3 Total Enrollment: 12,000 #### Official Trial Registration: - [NCT05308576(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05308576) - ### NCT05204589 Phase 3 China Total Enrollment: 10,420 #### Official Trial Registration: - [NCT05204589(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05204589) - ### NCT04942405 Phase 3 Turkey Total Enrollment: 40,800 #### Official Trial Registration: - [NCT04942405(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04942405) - ### NCT05077176 Phase 3 Turkey Total Enrollment: 7,400 #### Official Trial Registration: - [NCT05077176(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05077176) - ### NCT04992260 Phase 3 Chile Total Enrollment: 14,000 #### Official Trial Registration: - [NCT04992260(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04992260) - ### NCT05137418 Phase 3 China Total Enrollment: 1,000 #### Official Trial Registration: - [NCT05137418(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05137418) - ### NCT05225285 Phase 3 Brazil Total Enrollment: 1,120 #### Official Trial Registration: - [NCT05225285(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05225285) - ### NCT05156632 Phase 3 Pakistan Total Enrollment: 13,800 #### Official Trial Registration: - [NCT05156632(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05156632) - ### NCT04617483 Phase 3 China Total Enrollment: 1,040 #### Official Trial Registration: - [NCT04617483(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04617483) - ### NCT04651790 Phase 3 Chile Total Enrollment: 2,300 #### Official Trial Registration: - [NCT04651790(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04651790?term=vaccination&cond=covid&draw=2&rank=10) - ### NCT04800133 Phase 3 Hong Kong Total Enrollment: 900 #### Official Trial Registration: - [NCT04800133(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04800133?term=NCT04800133&draw=2&rank=1) - ### NCT04456595 Phase 3 Brazil Total Enrollment: 12,688 #### Official Trial Registration: - [NCT04456595(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04456595) - ### NCT04508075, 669/UN6.KEP/EC/2020 Phase 3 Indonesia Total Enrollment: 1,620 #### Official Trial Registration: - [NCT04508075(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04508075) - [669/UN6.KEP/EC/2020(Opens in new tab/window)](https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX) - ### NCT04582344 Phase 3 Turkey Total Enrollment: 13,000 #### Official Trial Registration: - [NCT04582344(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04582344) - ### PHRR210210-003308 Phase 2/3 Philippines Total Enrollment: 352 #### Official Trial Registration: - [PHRR210210-003308(Opens in new tab/window)](https://registry.healthresearch.ph/index.php/registry?view=research&layout=details&cid=3308) - ### NCT05593042 Phase 2 Chile Total Enrollment: 826 #### Official Trial Registration: - [NCT05593042(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05593042) - ### NCT05230940 Phase 2 Turkey Total Enrollment: 644 #### Official Trial Registration: - [NCT05230940(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05230940) - ### NCT04979949 Phase 2 Turkey Total Enrollment: 222 #### Official Trial Registration: - [NCT04979949(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04979949) - ### NCT05087368 Phase 2 Brazil Total Enrollment: 520 #### Official Trial Registration: - [NCT05087368(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05087368) - ### TCTR20210720005 Phase 2 Thailand Total Enrollment: 180 #### Official Trial Registration: - [TCTR20210720005(Opens in new tab/window)](https://www.thaiclinicaltrials.org/show/TCTR20210720005) - ### NCT04992182 Phase 2 Chile Total Enrollment: 534 #### Official Trial Registration: - [NCT04992182(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04992182) - ### NCT05049226 Phase 2 Thailand Total Enrollment: 1,320 #### Official Trial Registration: - [NCT05049226(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05049226) - ### NCT05150496 Phase 2 Turkey Total Enrollment: 640 #### Official Trial Registration: - [NCT05150496(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05150496) - ### NCT05254236 Phase 2 Hong Kong Total Enrollment: 150 #### Official Trial Registration: - [NCT05254236(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05254236) - ### NCT04884685 Phase 2 China Total Enrollment: 500 #### Official Trial Registration: - [NCT04884685(Opens in new tab/window)](https://www.clinicaltrials.gov/ct2/show/NCT04884685?term=NCT04884685&draw=2&rank=1) - ### NCT05226429 Phase 1/2 Indonesia Total Enrollment: 495 #### Official Trial Registration: - [NCT05226429(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05226429) - ### NCT05109559 Phase 1/2 Thailand Total Enrollment: 690 #### Official Trial Registration: - [NCT05109559(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05109559) - ### NCT05043259 Phase 1/2 China Total Enrollment: 420 #### Official Trial Registration: - [NCT05043259(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05043259) - ### NCT04352608 Phase 1/2 China Total Enrollment: 744 #### Official Trial Registration: - [NCT04352608(Opens in new tab/window)](https://clinicaltrials.gov/show/NCT04352608) - ### NCT04383574 Phase 1/2 China Total Enrollment: 422 #### Official Trial Registration: - [NCT04383574(Opens in new tab/window)](https://clinicaltrials.gov/show/NCT04383574) - ### NCT04551547 Phase 1/2 China Total Enrollment: 552 #### Official Trial Registration: - [NCT04551547(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT04551547) - ### NCT05583357 Phase 1 China Total Enrollment: 40 #### Official Trial Registration: - [NCT05583357(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05583357) - ### NCT05228613 Phase 1 Indonesia Total Enrollment: 175 #### Official Trial Registration: - [NCT05228613(Opens in new tab/window)](https://clinicaltrials.gov/ct2/show/NCT05228613)
Shard	165 (laksa)
Root Hash	5896860197286366765
Unparsed URL	org,trackvaccines!covid19,/vaccines/7/ s443